Swan-Swan Leong

2.0k total citations · 1 hit paper
11 papers, 1.5k citations indexed

About

Swan-Swan Leong is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Swan-Swan Leong has authored 11 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 2 papers in Surgery. Recurrent topics in Swan-Swan Leong's work include Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Swan-Swan Leong is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Swan-Swan Leong collaborates with scholars based in Singapore, United States and France. Swan-Swan Leong's co-authors include Tsu-Yi Chao, Emma Duffield, Yuri Rukazenkov, Tony Mok, Patrapim Sunpaweravong, Nagahiro Saijo, Ka‐Fai To, Georgina Speake, James Chih‐Hsin Yang and Sumitra Thongprasert and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and CHEST Journal.

In The Last Decade

Swan-Swan Leong

11 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)

2011 1.2k citations Masahiro Fukuoka, Yi‐Long Wu et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Swan-Swan Leong

Since Specialization

Citations

This map shows the geographic impact of Swan-Swan Leong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Swan-Swan Leong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swan-Swan Leong more than expected).

Fields of papers citing papers by Swan-Swan Leong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Swan-Swan Leong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Swan-Swan Leong. The network helps show where Swan-Swan Leong may publish in the future.

Co-authorship network of co-authors of Swan-Swan Leong

This figure shows the co-authorship network connecting the top 25 collaborators of Swan-Swan Leong. A scholar is included among the top collaborators of Swan-Swan Leong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Swan-Swan Leong. Swan-Swan Leong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS) breakdown → 2011 ·Journal of Clinical Oncology ·Masahiro Fukuoka, Yi‐Long Wu, Sumitra Thongprasert, Patrapim Sunpaweravong, Swan-Swan Leong, Virote Sriuranpong, Tsu-Yi Chao, Kazuhiko Nakagawa, (unknown), Nagahiro Saijo, Emma Duffield, Yuri Rukazenkov, Georgina Speake, Haiyi Jiang, Alison Armour, Ka‐Fai To, James Chih‐Hsin Yang, Tony Mok	1180
2	A Phase II Study of Pazopanib in Asian Patients with Recurrent/Metastatic Nasopharyngeal Carcinoma 2011 ·Clinical Cancer Research ·Wan‐Teck Lim, Quan‐Sing Ng, Percy Ivy, Swan-Swan Leong, Onkar Singh, Balram Chowbay, Fei Gao, Choon Hua Thng, Boon-Cher Goh, Daniel Shao-Weng Tan, Tong San Koh, Chee‐Keong Toh, Eng-Huat Tan	78
3	Cisplatin-Based Three Drugs Combination (NIP) as Induction and Adjuvant Treatment in Locally Advanced Non-small Cell Lung Cancer: Final Results 2008 ·Journal of Thoracic Oncology ·Maya Gottfried, Rodryg Ramlau, Maciej Krzakowski, (unknown), (unknown), Leona Koubková, Jubrail Dahabreh, Aleksandra Szczęsna, Guillermo López-Vivanco, Reury-Perng Perng, Francesco Carpagnano, Swan-Swan Leong, A. Fittipaldo, (unknown), D. Aubert, Dominique Grunenwald	23
4	Induction Concurrent Chemoradiotherapy Using Paclitaxel and CarboplatinCombination Followed by Surgery in Locoregionally Advanced Non-Small Cell Lung Cancer – Asian Experience 2008 ·Annals of the Academy of Medicine Singapore ·Swee‐Peng Yap, Wan‐Teck Lim, (unknown), Siew Wan Hee, Swan-Swan Leong, Kam-Weng Fong, Philip Eng, (unknown), (unknown), Thirugnanam Agasthian, Heng‐Nung Koong, Eng-Huat Tan	7
5	Survival of Small-cell Lung Cancer and its Determinants of Outcome in Singapore 2007 ·Annals of the Academy of Medicine Singapore ·Chee‐Keong Toh, Siew Wan Hee, Wan‐Teck Lim, Swan-Swan Leong, Kam-Weng Fong, Swee‐Peng Yap, (unknown), Philip Eng, Heng‐Nung Koong, Thirugnanam Agasthian, Eng-Huat Tan	6
6	Differences between small-cell lung cancer and non-small-cell lung cancer among tobacco smokers 2007 ·Lung Cancer ·Chee‐Keong Toh, Fei Gao, Wan‐Teck Lim, Swan-Swan Leong, Kam-Weng Fong, Swee‐Peng Yap, Anne Ann Ling Hsu, Philip Eng, Heng‐Nung Koong, Thirugnanam Agasthian, Eng-Huat Tan	22
7	Electroacupuncture for Refractory Acute Emesis Caused by Chemotherapy 2006 ·The Journal of Alternative and Complementary Medicine ·Su Pin Choo, Keng-He Kong, Wan‐Teck Lim, Fei Gao, Karen Sui Geok Chua, Swan-Swan Leong	18
8	The Impact of Smoking Status on the Behavior and Survival Outcome of Patients With Advanced Non-small Cell Lung Cancer 2004 ·CHEST Journal ·Chee‐Keong Toh, (unknown), Wan‐Teck Lim, Swan-Swan Leong, Kam-Weng Fong, Joseph Wee, Eng-Huat Tan	117
9	Concurrent chemoradiotherapy in locoregionally recurrent nasopharyngeal carcinoma 2004 ·International Journal of Radiation OncologyBiologyPhysics ·Donald Poon, Swee‐Peng Yap, (unknown), Yin‐Bun Cheung, Swan-Swan Leong, Joseph Wee, Terence Tan, Kam-Weng Fong, E.T. Chua, Eng-Huat Tan	33
10	Caring for the Dying Patient With Lung Cancer 2002 ·CHEST Journal ·Gerard A. Silvestri, Carol A. Sherman, Todd Williams, Swan-Swan Leong, Patrick A. Flume, Andrew T. Turrisi	16
11	Irinotecan and gemcitabine in patients with solid tumors: phase I trial. 2002 ·PubMed ·Caio Max S. Rocha Lima, Swan-Swan Leong, Carol A. Sherman, (unknown), (unknown), Ahmad R. Safa, Mark R. Green	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact